Essential biopharma news and analysis

Independent journalism since 2016

Read the news on your terms. Uncluttered design. Sharp writing. And it's absolutely free, or you can pay to get Endpoints News without the email advertising. Corporate subscriptions are one simple price, regardless of size. With Endpoints, you'll never miss an important drug development story again.

Subscribe to Endpoints News

About You


ENDPOINTS NEWSby John Carroll & team — all the news at 11:30am ET

EARLY EDITIONby Arsalan Arif — news and links at 7:15am ET

ENDPOINTS MANUFACTURINGWeekly biopharma manufacturing news report, Thursday 2pm ET

ENDPOINTS WEEKLYRecaps the week's most important stories on Saturdays 6am ET

ENDPOINTS FDA+by Zachary Brennan — Regulatory news and analysis for drug developers, Wednesday 2pm ET

ENDPOINTS MARKETING RXCovers advertising and the multibillion-dollar drug commercialization world, Tuesday 2pm ET

Endpoints News is an independent journalism company. Readers fund our growth with premium subscriptions, ensuring our long-term viability. Advertising from trusted partners screened by Endpoints guarantees access for all to quality journalism. Here's our privacy policy.